Plastic Surgery Weekly

The week in peer-reviewed plastic surgery research

10 Issues 2,312 screened 707 selected since May 2026

Every Sunday, the week's new plastic surgery research, read and ranked. This is the archive. The story, the journals, and how each issue is made live at The Plastic Surgeon's Toolkit.

Latest Issue

Issue 10 · Sunday, July 19, 2026 213 screened · 64 selected Read → This Week in Brief

Reconstruction leads with a Plast Reconstr Surg series on suzetrigine, a non-opioid NaV1.8 inhibitor added to multimodal analgesia: 90.9% of aesthetic and reconstructive patients needed no opioid rescue, 90.7% rated pain control good to excellent, and the few who did use opioids took a mean of 2.4 tablets over 2.0 days. The IDEAL BREAST cohort in the same journal finds immediate and delayed autologous reconstruction under postmastectomy radiotherapy produce comparable major complication rates (6.4% vs 3.5%, p=.29) and comparable BREAST-Q scores at a median 5.0 years. A multicentre Ann Surg Oncol RCT of da Vinci SP robotic versus open nipple-sparing mastectomy reports identical positive-margin counts, six patients each, but longer operative times, 141.6 versus 83.9 minutes. Robotics recur in a J Plast Reconstr Aesthet Surg review of early microsurgical adoption, most often for immediate lymphatic reconstruction (52.8%), again with longer anastomosis times that shorten along a learning curve. In J Reconstr Microsurg, intraoperative EMG puts cervical phrenic nerve variation at 63.3%, roughly double the 31.8% found by cadaveric dissection, with variant amplitudes reaching half the main nerve in 44.4% of recordable cases.

Earlier Issues Newest first